Where does Arvinas Operations, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arvinas Operations, Inc. ranks #6,218 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arvinas Operations, Inc. hold?

Arvinas Operations, Inc. holds 54 US utility patents granted between 2020 and 2025, spanning 11 technology areas.

What is Arvinas Operations, Inc.'s Innovation Score?

Arvinas Operations, Inc. has an Innovation Score of 47.0 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Arvinas Operations, Inc. focus on?

Arvinas Operations, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 53 patents, ranking #145 of 3,165 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Arvinas Operations, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Arvinas Operations, Inc..

What does claim depth mean for Arvinas Operations, Inc.'s patents?

Arvinas Operations, Inc.'s patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arvinas Operations, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Arvinas Operations, Inc.

USPTO PatentsView assignee record - 54 granted patents across 11 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arvinas ranks #6,218 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 11 technology areas.

#6,218
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.0/100): 15.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R6218 · US Corporation #6,218 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 54 grants
UPPER-Q #6,218/49,997
PHOTO-FINISH Ampleon Netherlands…
CPC-FOCUS C07D · 11 areas
INNOV-PAR 47.0/100
CLAIMS-RICH 15.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Ampleon Netherlands B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arvinas’s 47.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (29%) Velocity 12.1 pts (26%) Breadth 11.7 pts (25%) Claim depth 9.4 pts (20%)

Qualcomm Incorporated · highest

85
Arvinas Operations · this assignee

47
Edgewell Personal… · near

47
Natera · near

47
Saam · near

47
Ultravision · near

47
3D Lighting… · lowest

7

What this shows Arvinas's Innovation Score is 47.0/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arvinas?

Each dot is one of Arvinas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arvinas’s own 15.6 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arvinas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arvinas's grants concentrate

Arvinas Operations, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 98.1% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2024 (19 grants) versus a trough of 4 in 2023. By volume, Arvinas sits between Ampleon Netherlands B.V. and Beijing Volcano Engine Technology Co., Ltd..

Arvinas's three-year grant acceleration

Arvinas Operations, Inc. shows 29 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ampleon Netherlan…

54
Analog Photonics

54
Anisa Internation…

54
Applied Minds

54
Aseko

54
Beijing Unisoc Co…

54
Blanco + KG

54
Beijing Volcano E…

54
Arvinas Operations ◀

54

What this shows Arvinas holds 54 patents at rank #6,219, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arvinas

By rank, the assignees closest to #6,219 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Arvinas's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Arvinas, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Arvinas ranks #145 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Natera, Inc. 47 Edgewell Personal Care Brands, LLC 47 Saam, Inc. 47 Ultravision Technologies, LLC 47

Similar claim depth

Nearest assignees by average claims per patent (15.6 here).

Assa Abloy Entrance Systems AB 15.6 avg Illinois Tool Works Inc. 15.6 avg Tendyne Holdings, Inc. 15.6 avg thyssenkrupp Elevator Corporation 15.6 avg

Arvinas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Arvinas Operations, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	8	14.8%
2021	8	14.8%
2022	6	11.1%
2023	4	7.4%
2024	19	35.2%
2025partial year	9	16.7%

Which technologies does Arvinas Operations, Inc. patent most?

C07D - Heterocyclic Compounds 53

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 46

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 43

C07K - Peptides 9

C07C - Acyclic OR Carbocyclic Compounds 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C12Y - Enzymes 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arvinas Operations, Inc.'s patent record in context - here's where to go next.

Arvinas Operations, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 98.1% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #6,218 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arvinas Operations, Inc. against Ampleon Netherlands B.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.